Keay Nakae
Stock Analyst at Chardan Capital
(3.46)
# 2,246
Out of 4,455 analysts
598
Total ratings
39.8%
Success rate
3%
Average return
Main Sectors:
Stocks Rated by Keay Nakae
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRQR ProQR Therapeutics | Reiterated: Buy | $4 → $3 | $1.53 | +96.08% | 40 | Jun 25, 2026 | |
| SABS SAB Biotherapeutics | Reiterated: Buy | $14 → $16 | $3.80 | +321.05% | 20 | Jun 16, 2026 | |
| BME: PHM Pharma Mar, S.A. | Maintained: Buy | €120.00 → €100.00 | $73.00 | +36.99% | 8 | Jun 14, 2026 | |
| CAMP Camp4 Therapeutics | Initiated Coverage: Buy | $6.5 | $4.20 | +54.76% | 1 | Jun 10, 2026 | |
| IBIO iBio, Inc. | Reiterated: Buy | $5 | $1.67 | +199.40% | 6 | May 14, 2026 | |
| COYA Coya Therapeutics | Maintained: Buy | $14 | $5.50 | +154.55% | 19 | May 12, 2026 | |
| DYN Dyne Therapeutics | Maintained: Buy | $38 | $20.94 | +81.47% | 17 | May 11, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Reiterated: Buy | $80 → $90 | $78.89 | +14.08% | 46 | May 8, 2026 | |
| KRRO Korro Bio | Reiterated: Buy | $15 | $12.70 | +18.11% | 5 | May 7, 2026 | |
| SLN Silence Therapeutics | Maintained: Buy | $35 → $27 | $10.14 | +166.27% | 17 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $425 | $291.37 | +45.86% | 51 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $27.04 | +10.95% | 4 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | ¥800 | $246.00 | +225.20% | 1 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $4.24 | +371.70% | 12 | Mar 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $2.5 → $3 | $2.94 | +2.04% | 6 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $0.67079 | +5,863.12% | 1 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $32.00 | +9.38% | 1 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €10.00 → €5.00 | $0.874 | +472.08% | 5 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $85 | $87.68 | -3.06% | 2 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $25 → $6 | $7.06 | n/a | 19 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $14.54 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.00001 | n/a | 4 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.68 | n/a | 20 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.68 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 | $0.85 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.5 → $5 | $4.58 | n/a | 47 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.75 | n/a | 7 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $8 | $3.80 | n/a | 14 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 13 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $13.19 | n/a | 16 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $13.17 | n/a | 1 | Mar 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.53 | n/a | 31 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.88 | n/a | 5 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $21.03 | n/a | 6 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.3956 | n/a | 18 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.53 | n/a | 1 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $100 → $50 | $0.000001 | n/a | 8 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.40 | n/a | 15 | Sep 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.0803 | n/a | 2 | Oct 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.28 | n/a | 15 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.37 | n/a | 8 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2,126.00 | n/a | 9 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.88 | n/a | 9 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 6 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.75 | n/a | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $4.5 | $1.50 | n/a | 9 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.8012 | n/a | 2 | Nov 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $2 | $5.40 | n/a | 11 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $67.27 | n/a | 1 | Mar 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0002 | n/a | 2 | Jan 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $17.90 | n/a | 3 | Jun 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $10.73 | n/a | 1 | Jun 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.3 → $4.5 | $1.08 | n/a | 3 | Feb 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $2.55 | n/a | 3 | Dec 6, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $1.09 | n/a | 1 | Aug 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.25 | $2.15 | n/a | 1 | Aug 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.25 → $2 | $0.0001 | n/a | 4 | Jul 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $6 | $1.77 | n/a | 4 | Mar 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $1.83 | n/a | 1 | Dec 3, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 | $4.20 | n/a | 1 | Aug 6, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $100 → $18 | $0.0002 | n/a | 3 | May 15, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $4.99 | n/a | 1 | Oct 7, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.5 | $0.0001 | n/a | 1 | Jul 3, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $2.3 | $0.2498 | n/a | 1 | Jun 25, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $46.23 | n/a | 1 | May 16, 2012 |
ProQR Therapeutics
Jun 25, 2026
Reiterated: Buy
Price Target: $4 → $3
Current: $1.53
Upside: +96.08%
SAB Biotherapeutics
Jun 16, 2026
Reiterated: Buy
Price Target: $14 → $16
Current: $3.80
Upside: +321.05%
Pharma Mar, S.A.
Jun 14, 2026
Maintained: Buy
Price Target: €120.00 → €100.00
Current: $73.00
Upside: +36.99%
Camp4 Therapeutics
Jun 10, 2026
Initiated Coverage: Buy
Price Target: $6.5
Current: $4.20
Upside: +54.76%
iBio, Inc.
May 14, 2026
Reiterated: Buy
Price Target: $5
Current: $1.67
Upside: +199.40%
Coya Therapeutics
May 12, 2026
Maintained: Buy
Price Target: $14
Current: $5.50
Upside: +154.55%
Dyne Therapeutics
May 11, 2026
Maintained: Buy
Price Target: $38
Current: $20.94
Upside: +81.47%
Arrowhead Pharmaceuticals
May 8, 2026
Reiterated: Buy
Price Target: $80 → $90
Current: $78.89
Upside: +14.08%
Korro Bio
May 7, 2026
Reiterated: Buy
Price Target: $15
Current: $12.70
Upside: +18.11%
Silence Therapeutics
May 7, 2026
Maintained: Buy
Price Target: $35 → $27
Current: $10.14
Upside: +166.27%
May 1, 2026
Reiterated: Buy
Price Target: $425
Current: $291.37
Upside: +45.86%
Apr 21, 2026
Maintained: Buy
Price Target: $30
Current: $27.04
Upside: +10.95%
Apr 7, 2026
Initiated Coverage: Buy
Price Target: ¥800
Current: $246.00
Upside: +225.20%
Mar 12, 2026
Maintained: Buy
Price Target: $20
Current: $4.24
Upside: +371.70%
Feb 24, 2026
Upgraded: Buy
Price Target: $2.5 → $3
Current: $2.94
Upside: +2.04%
Jan 5, 2026
Maintained: Buy
Price Target: $40
Current: $0.67079
Upside: +5,863.12%
Jan 5, 2026
Maintained: Buy
Price Target: $35
Current: $32.00
Upside: +9.38%
Sep 30, 2025
Maintained: Buy
Price Target: €10.00 → €5.00
Current: $0.874
Upside: +472.08%
Sep 25, 2025
Maintained: Buy
Price Target: $60 → $85
Current: $87.68
Upside: -3.06%
May 8, 2025
Downgraded: Hold
Price Target: $25 → $6
Current: $7.06
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $14.54
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $0.00001
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $0.68
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $1.68
Upside: n/a
Dec 20, 2024
Maintained: Hold
Price Target: $12
Current: $0.85
Upside: n/a
Nov 19, 2024
Maintained: Buy
Price Target: $4.5 → $5
Current: $4.58
Upside: n/a
Nov 18, 2024
Reiterated: Buy
Price Target: $6
Current: $1.75
Upside: n/a
Nov 12, 2024
Maintained: Buy
Price Target: $10 → $8
Current: $3.80
Upside: n/a
Mar 14, 2024
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Dec 12, 2023
Rated: Hold
Price Target: n/a
Current: $13.19
Upside: n/a
Mar 9, 2023
Reiterated: Buy
Price Target: n/a
Current: $13.17
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $8.53
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $8.88
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $21.03
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.3956
Upside: n/a
Feb 6, 2023
Reiterated: Buy
Price Target: n/a
Current: $9.53
Upside: n/a
Nov 16, 2022
Downgraded: Hold
Price Target: $100 → $50
Current: $0.000001
Upside: n/a
Sep 30, 2022
Rated: Hold
Price Target: n/a
Current: $2.40
Upside: n/a
Oct 18, 2021
Reiterated: Buy
Price Target: n/a
Current: $0.0803
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $1.28
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $3.37
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $2,126.00
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $6.88
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $8.75
Upside: n/a
Jun 10, 2021
Reiterated: Hold
Price Target: $8 → $4.5
Current: $1.50
Upside: n/a
Nov 20, 2020
Rated: Hold
Price Target: n/a
Current: $0.8012
Upside: n/a
Jul 30, 2020
Rated: Hold
Price Target: $2
Current: $5.40
Upside: n/a
Mar 23, 2020
Reiterated: Buy
Price Target: n/a
Current: $67.27
Upside: n/a
Jan 28, 2020
Rated: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
Jun 10, 2019
Rated: Hold
Price Target: n/a
Current: $17.90
Upside: n/a
Jun 10, 2019
Rated: Hold
Price Target: n/a
Current: $10.73
Upside: n/a
Feb 16, 2017
Maintained: Buy
Price Target: $3.3 → $4.5
Current: $1.08
Upside: n/a
Dec 6, 2016
Maintained: Buy
Price Target: $6
Current: $2.55
Upside: n/a
Aug 23, 2016
Maintained: Buy
Price Target: $4
Current: $1.09
Upside: n/a
Aug 12, 2016
Reiterated: Buy
Price Target: $2.25
Current: $2.15
Upside: n/a
Jul 8, 2016
Maintained: Buy
Price Target: $2.25 → $2
Current: $0.0001
Upside: n/a
Mar 28, 2016
Reiterated: Buy
Price Target: $12 → $6
Current: $1.77
Upside: n/a
Dec 3, 2014
Initiated Coverage: Buy
Price Target: $16
Current: $1.83
Upside: n/a
Aug 6, 2014
Downgraded: Hold
Price Target: $4
Current: $4.20
Upside: n/a
May 15, 2014
Downgraded: Hold
Price Target: $100 → $18
Current: $0.0002
Upside: n/a
Oct 7, 2013
Initiated Coverage: Buy
Price Target: $13
Current: $4.99
Upside: n/a
Jul 3, 2013
Reiterated: Buy
Price Target: $5.5
Current: $0.0001
Upside: n/a
Jun 25, 2013
Initiated Coverage: Buy
Price Target: $2.3
Current: $0.2498
Upside: n/a
May 16, 2012
Initiated Coverage: Buy
Price Target: n/a
Current: $46.23
Upside: n/a